Background

Obesity (BMI >30) is a global pandemic associated with cardiovascular disease (CVD), increased morbidity and mortality, decreased life expectancy, and multiple comorbidities. It alters cardiac structure and function, causes circulatory changes, and leads to endothelial dysfunction. In addition, it impairs the assessment of CVD by reducing the sensitivity of the physical exam, causing alterations in the electrocardiogram (EKG), reducing exercise tolerance, and affecting the resolution of imaging studies.

Aim

In this study, we aim to evaluate the impact of obesity on efficacy and cost-effectiveness of cardiac stress testing.

Aim

In this study, we aim to evaluate the impact of obesity on efficacy and cost-effectiveness of cardiac stress testing.

Only gold members can continue reading. Log In or Register to continue

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on Facebook (Opens in new window)

Related

Related posts:

1. Editorial Note
2. Acute type A aortic dissection in a patient with ventricular septal defect
3. Do ON versus OFF hours and transfer distance impact in-hospital outcomes for patients presenting with STEMI?
4. Decreasing trend in in-hospital mortality of patients undergoing percutaneous coronary intervention regardless of race or gender with persistent higher mortality rates in women and minorities in the United States

Stay updated, free articles. Join our Telegram channel

Join

Full access? Get Clinical Tree